FDA authorizes labs to use Zika detection kit by InBios
Top Priority Sector: cbrne_detectionSeattle Aug. 19, 2016InBios announced today that it received an Emergency Use Authorization (EUA) from the FDA for its ZIKV Detect™ IgM Capture ELISA. The product is intended for the presumptive detection of Zika virus IgM antibodies in human sera collected from individuals meeting CDC Zika virus clinical criteria (e.g., a history of clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria. Thi
Read more »